The Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO, formerly Ludwig Boltzmann Cluster Oncology (LBC ONC)), which focuses on tumor stem cell research, was initially established from the Ludwig Boltzmann Institute for Clinical Experimental Oncology at the Medical University of Vienna and the Ludwig Boltzmann Institute for Leukemia Research and Hematology at the Hanusch Hospital.
The fusion of research groups from the Department for Internal Medicine I, Department of Dermatology, Clinical Institute of Medical Chemistry and Laboratory Diagnostics, and the Center for Pathophysiology at the Medical University of Vienna and the Department of Oncology of the Hanusch Hospital concentrating on one topic - ‘tumor stem cell research’, is a successful example of an interdisciplinary focus on a crucial topic. Scientific expertise and resources from different research groups flow into the project. Working groups of physicians and basic researchers of different specialties are involved. The resulting synergies will optimize tumor stem cell research.